← Back to Analyst Consensus 
SKIN Hold
SkinHealth Systems Inc.
Current Price —
Implied Upside —
Analysts 14
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 2 reiterations from 2 firms
Next Earnings
Nov 4, 2026 (8 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 22, 2026 | Canaccord Genuity | maintain | Hold → Hold | — | 48% |
| Oct 19, 2026 | Jefferies | maintain | Hold → Hold | — | 52% |
| Aug 12, 2026 | TD Cowen | maintain | Hold → Hold | — | 54% |
| May 20, 2026 | Roth Capital | reiterate | Buy → Buy | — | 52% |
| May 1, 2026 | Canaccord Genuity | maintain | Hold → Hold | — | 48% |
| Mar 16, 2026 | TD Cowen | maintain | Hold → Hold | — | 54% |
| Mar 13, 2026 | Canaccord Genuity | maintain | Hold → Hold | — | 48% |
| Jan 21, 2026 | TD Cowen | maintain | Hold → Hold | $1.65 | 54% |
| Sep 22, 2025 | TD Cowen | maintain | Hold → Hold | $2.5 | 54% |
| Sep 19, 2025 | Roth Capital | initiate | — → Buy | $3.5 | 52% |
| May 5, 2025 | Canaccord Genuity | maintain | Hold → Hold | $1.25 | 48% |
| Mar 13, 2025 | Canaccord Genuity | maintain | Hold → Hold | $1.5 | 48% |
| Nov 13, 2024 | Canaccord Genuity | maintain | Hold → Hold | $1.75 | 48% |
| Aug 12, 2024 | Canaccord Genuity | maintain | Hold → Hold | $1.25 | 48% |
| Aug 9, 2024 | Piper Sandler | reiterate | Underweight → Underweight | $1 | 54% |
| Jul 26, 2024 | Stifel | maintain | Hold → Hold | $2 | 54% |
| Jul 11, 2024 | Piper Sandler | maintain | Underweight → Underweight | $1.5 | 54% |
| May 13, 2024 | DA Davidson | maintain | Buy → Buy | $5 | 55% |
| May 13, 2024 | TD Cowen | maintain | Hold → Hold | $3 | 54% |
| May 10, 2024 | Piper Sandler | maintain | Underweight → Underweight | $2.5 | 54% |
| Mar 15, 2024 | DA Davidson | maintain | Buy → Buy | $5 | 55% |
| Mar 14, 2024 | Canaccord Genuity | maintain | Hold → Hold | $4 | 48% |
| Mar 13, 2024 | Stifel | reiterate | Hold → Hold | $4 | 54% |
| Mar 13, 2024 | TD Cowen | maintain | Market Perform → Market Perform | $4 | 54% |
| Mar 13, 2024 | Piper Sandler | reiterate | Underweight → Underweight | $3 | 54% |
| Feb 29, 2024 | Canaccord Genuity | maintain | Hold → Hold | $3 | 48% |
| Nov 15, 2023 | Jefferies | downgrade | Buy → Hold | $1.5 | 52% |
| Nov 14, 2023 | Stifel | maintain | Hold → Hold | $3 | 54% |
| Nov 14, 2023 | Benchmark | downgrade | Buy → Hold | $0 | 54% |
| Nov 14, 2023 | William Blair | downgrade | Outperform → Market Perform | $0 | 48% |
| Nov 14, 2023 | TD Cowen | downgrade | Outperform → Market Perform | $2.5 | 54% |
| Nov 14, 2023 | Raymond James | downgrade | Market Perform → Underperform | $0 | 53% |
| Nov 14, 2023 | Piper Sandler | downgrade | Overweight → Underweight | $2 | 54% |
| Nov 14, 2023 | Canaccord Genuity | downgrade | Buy → Hold | $2.5 | 48% |
| Nov 14, 2023 | JP Morgan | downgrade | Neutral → Underweight | $0 | 55% |
| Sep 13, 2023 | Benchmark | reiterate | Buy → Buy | $23 | 54% |
| Aug 10, 2023 | TD Cowen | maintain | Outperform → Outperform | $9 | 54% |
| Aug 10, 2023 | DA Davidson | maintain | Buy → Buy | $16.5 | 55% |
| Aug 8, 2023 | Benchmark | reiterate | Buy → Buy | $23 | 54% |
| Jun 21, 2023 | Stifel | downgrade | Buy → Hold | $10 | 54% |
| May 26, 2023 | JP Morgan | maintain | Neutral → Neutral | $12 | 55% |
| May 18, 2023 | Benchmark | reiterate | Buy → Buy | $23 | 54% |
| May 11, 2023 | DA Davidson | reiterate | — → Buy | $35 | 55% |
| Mar 28, 2023 | Canaccord Genuity | reiterate | — → Buy | $18 | 48% |
| Mar 20, 2023 | Exane BNP Paribas | upgrade | Underperform → Neutral | $0 | 52% |
| Mar 14, 2023 | Benchmark | reiterate | — → Buy | $23 | 54% |
| Mar 1, 2023 | DA Davidson | maintain | — → Buy | $35 | 55% |
| Feb 28, 2023 | Benchmark | reiterate | — → Buy | $23 | 54% |
| Feb 16, 2023 | Cowen & Co. | maintain | — → Outperform | $15 | — |
| Nov 23, 2022 | Goldman Sachs | maintain | — → Buy | $19 | 54% |
Price Target Trend
Apr 13, 2026 Latest: $15.67 Oct 25, 2026
EPS Estimates
+1q $-0.42
Lo: $-0.98 Hi: $0.00
8 analysts ▲1
+1y $3.82
Lo: $3.82 Hi: $3.82
1 analysts ▲1
0y $2.56
Lo: $2.56 Hi: $2.56
1 analysts 0q $0.00
Lo: $0.00 Hi: $0.00
1 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days